Lexeo Therapeutics Inc. (LXEO)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
4. 69
+0.13
+2.8509%
$
362.77M Market Cap
- P/E Ratio
- Div Yield
730,100 Volume
- Eps
$ 4.56
Previous Close 
Want to track LXEO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lexeo Therapeutics Inc. (LXEO) Statistics
Valuation metrics
Market Cap 362.77M
Enterprise value 303.86M
Trailing P/E (ttm) -3.23
Forward P/E -
PEG ratio -0.04
Price/Sales (ttm) -
Price/Book (mrq) 1.64
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.57
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 721.47K
Average volume (90 days) 788.26K
Price summary
52-Week low 3.6
52-Week high 10.99
Beta -
50-Day moving average 4.55
200-Day moving average 6.54
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.35%
Return on equity -0.47%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.88
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 14.16%
Book value per share (mrq) 2.85
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
